TEVA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TEVA shares is 742, representing 58.17% of the company's common stock.

MONACO ASSET MANAGEMENT SAM, in the last quarter, reduced its stake in TEVA by -0.23% restricting it's holding to 1.36 million shares of worth nearly $19.25M. ALLIANZ ASSET MANAGEMENT GMBH also lessened -35.68% of the TEVA shares from its portfolio, reducing its holding to 1.35 million shares of worth $19.08M. VONTOBEL HOLDING LTD. also shunned TEVA shares holding by -52.46% last quarter which brought its holding to 1.09 million shares worth $15.35M.

As per its latest 13F filing, UBS GROUP AG increased its stake in TEVA by 143.58% in the last quarter. The institutional holder raised its holding to 2.2 million shares having worth more than $31.02M. JANNEY MONTGOMERY SCOTT LLC also added 13.63% more shares of TEVA to its portfolio, raising its holding to 1.37 million shares of worth $19.37M. SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) also increased its TEVA shares holding by 469.68% which brought its holding to 1.28 million shares worth $18.01M.

The insider with the most stakes in TEVA is MIGNONE ROBERTO , director at the company. Additionally, TEVA stock is highly held by EVP, International Markets Sabag Mark and EVP, Chief Financial Officer Kalif Eliyahu Sharon among others.

Company executives, directors, and other insiders own 0% percent of Teva Pharmaceutical Industries Limited's stock. Within the last six months, there have been 6 transaction(s) in which TEVA insiders have sold stock, totaling 477.99K shares. Insiders that have sold shares include MIGNONE ROBERTO, FOX CHRISTINE, and DANIELL RICHARD.

There have been 0 transaction(s) during the past 6-months in which Teva Pharmaceutical Industries Limited insiders have bought stock, totalling 0 shares

Around 793.01K Teva Pharmaceutical Industries Limited shares are held by insiders, which represents about 0% of TEVA stock.

TEVA director, MIGNONE ROBERTO holds the largest portfolio of the company's shares. TEVA shares owned by MIGNONE total nearly 695 thousand.

UBS GROUP AG is the largest institutional owner in TEVA which holds 2.2 million shares worth $31.02M or 0.2% of the total TEVA shares outstanding followed by MIVTACHIM THE WORKERS SOCIAL INSURANCE FUND LTD. (UNDER SPECIAL MANAGEMENT) with ownership of 1.45 million shares representing 0.13% of the TEVA ownership. JANNEY MONTGOMERY SCOTT LLC is the third largest stakeholder with 1.37 million shares or 0.12% of the ownership worth more than $19.37M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TEVA is concerned, it is a stock which is optionable.

Number of TEVA shares short is 27.13M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 1.13B shares of TEVA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TEVA has 1.13B shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TEVA is 2.39.